Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Randomized Pilot Study of Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients

NCT05632133 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT05632133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05632133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Randomized Pilot Study of Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients
Lead sponsor
Kafrelsheikh University
Phase
Phase 3
Overall status
Completed
Start date
June 1, 2022
Completion date
August 10, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, migraine disorders